GLP-1 Market
LLY $1169.60 ▼ -1.6% NVO $38.18 ▼ -0.2% PFE $27.82 ▼ -0.6% VKTX $27.73 ▼ -2.8% KLRA $10.00 ▼ -5.0% GPCR $25.67 ▼ -3.8% RHHBY $53.29 ▼ -1.4%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Cyproheptadine Hydrochloride

Company
Corey Hawes
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
6 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

6 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 9, 2026

Find a Clinical Trial Near Me

See recruiting studies for Cyproheptadine Hydrochloride and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT04211259

    Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization

    Not yet reported Rutgers, The State University of New Jersey 70 participants Est. completion 2027-06-30 2 sites
    Other conditions: Plasma Cell Myeloma
    View official trial listing →
  • Recruiting NCT NCT05421416

    Loratadine for the Prevention of G-CSF-related Bone Pain

    Not yet reported AHS Cancer Control Alberta 78 participants Est. completion 2026-12-01 1 site
    Other conditions: Stem Cell Transplant Complications
    View official trial listing →
  • Recruiting NCT NCT05469165

    Serotonin Receptor Blockers in Ischemic Mitral Regurgitation

    Not yet reported Laval University 214 participants Est. completion 2027-09 1 site Stand-alone
    Other conditions: Ischemic Mitral Regurgitation
    View official trial listing →
  • Recruiting NCT NCT07101445

    Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

    Not yet reported Emory University 94 participants Est. completion 2027-12-31 1 site
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Recruiting NCT NCT07300735

    Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers

    Not yet reported Alexandria University 88 participants Est. completion 2027-07 1 site
    Other conditions: Hematologic Malignancy, Neutropenia, Bone Pain
    View official trial listing →
  • Recruiting NCT NCT07661459

    Optimizing Ancillary Therapies With Immune Checkpoint Inhibitors for Solid Tumors (OAT ICI)

    Not yet reported Val Adams 98 participants Est. completion 2027-07-31 1 site
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT00066248

    Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

    Not yet reported University of South Florida 70 participants Est. completion 2007-08 43 sites Stand-alone
    Other conditions: Brain Tumor, Central Nervous System Tumors, Cachexia, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00319995

    Effects of Loratadine/Montelukast vs Pseudoephedrine and Placebo in Patients With Seasonal Allergic Rhinitis (Study P04095) (COMPLETED)

    Not yet reported Organon and Co 1095 participants Est. completion 2006-06-28
    Other conditions: Rhinitis, Allergic, Seasonal
    View official trial listing →
  • Completed NCT NCT00423995

    Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822)

    Not yet reported Organon and Co 379 participants Est. completion 2007-03-10
    Other conditions: Seasonal Allergic Rhinitis
    View official trial listing →
  • Completed NCT NCT00449072

    Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)

    Not yet reported Sanofi 299 participants Est. completion 2011-10 1 site
    Other conditions: Rhinitis, Allergic, Perennial
    View official trial listing →
  • Completed NCT NCT00481676

    Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria

    Not yet reported Novartis 49 participants Est. completion 2009-04 11 sites
    Other conditions: Chronic Urticaria
    View official trial listing →
  • Completed NCT NCT00550550

    Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)

    Not yet reported ALK-Abelló A/S 345 participants Est. completion 2009-09
    Other conditions: Rhinoconjunctivitis, Rhinitis, Conjunctivitis, Allergy
    View official trial listing →
  • Completed NCT NCT00561717

    A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis

    Not yet reported Bayer 70 participants Est. completion 2008-02 1 site
    Other conditions: Seasonal Allergic Rhinitis
    View official trial listing →
  • Completed NCT NCT00562159

    Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)

    Not yet reported ALK-Abelló A/S 439 participants Est. completion 2009-09
    Other conditions: Rhinoconjunctivitis, Rhinitis, Conjunctivitis, Allergy
    View official trial listing →
  • Completed NCT NCT00721331

    A Phase I Study to Assess the Safety and Tolerability of Topical CRx-197 Formulations in Healthy Volunteers

    Not yet reported Zalicus 20 participants Est. completion 2008-09 1 site
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT00730912

    Post Approval Pharmacokinetic Study of Loratadine in Japanese Pediatric and Adult Patients (Study P05539)

    Not yet reported Merck Sharp & Dohme LLC 261 participants Est. completion 2008-12
    Other conditions: Perennial Allergic Rhinitis
    View official trial listing →
  • Completed NCT NCT00762983

    Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED)

    Merck Sharp & Dohme LLC 1003 participants Est. completion 2009-02
    Other conditions: Rhinitis, Allergic, Seasonal, Rhinitis, Allergic, Perennial, Urticaria, Pruritus
    View official trial listing →
  • Completed NCT NCT00776217

    Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions

    Not yet reported Ranbaxy Laboratories Limited 80 participants Est. completion 2006-09
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00776282

    Bioequivalence Study of Loratadine Orally Disintegrating Tablets 10 mg Under Fed Conditions

    Not yet reported Ranbaxy Laboratories Limited 80 participants Est. completion 2006-09
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00837915

    Bioequivalnce Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fasting Conditions

    Not yet reported Ranbaxy Laboratories Limited 40 participants Est. completion 2002-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00946608

    To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets

    Not yet reported Sandoz 30 participants Est. completion 2005-08
    Other conditions: Allergy
    View official trial listing →
  • Terminated NCT NCT00949117

    Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer

    Not yet reported University of South Florida 9 participants Est. completion 2011-11 Stand-alone
    Other conditions: Leukemia, Lymphoma, Malnutrition, Myelodysplastic Syndromes, Unspecified Childhood Solid Tumor, Protocol Specific, Weight Changes
    View official trial listing →
  • Completed NCT NCT00963573

    Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428)

    Not yet reported Merck Sharp & Dohme LLC 100 participants Est. completion 2006-11
    Other conditions: Rhinitis
    View official trial listing →
  • Completed NCT NCT00963599

    Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)

    Not yet reported Organon and Co 907 participants Est. completion 1999-11
    Other conditions: Seasonal Allergic Rhinitis
    View official trial listing →
  • Completed NCT NCT00979901

    Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)

    Not yet reported Organon and Co 1577 participants Est. completion 2000-05
    Other conditions: Seasonal Allergic Rhinitis
    View official trial listing →
  • Completed NCT NCT01007864

    Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists

    Not yet reported Desitin Arzneimittel GmbH 80 participants Est. completion 2011-12 12 sites
    Other conditions: Idiopathic Parkinson's Disease
    View official trial listing →
  • Withdrawn NCT NCT01055756

    Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis

    Not yet reported Azidus Brasil Est. completion 2010-06 1 site
    Other conditions: Allergic Rhinitis
    View official trial listing →
  • Completed NCT NCT01076283

    A Study on the Biobehavioral Mechanisms of Baclofen and Alcohol Drinking

    Not yet reported Brown University 14 participants Est. completion 2010-05 1 site
    Other conditions: Alcoholism
    View official trial listing →
  • Terminated NCT NCT01132547

    Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

    Not yet reported University of South Florida 22 participants Est. completion 2014-01 14 sites Stand-alone
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT01228630

    Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis.

    Not yet reported Azidus Brasil 156 participants Est. completion 2012-05 1 site
    Other conditions: Perennial Allergic Rhinitis
    View official trial listing →
  • Status unknown NCT NCT01295450

    Study to Evaluate the Efficacy and Tolerability of Apevinat BC Compared to Vitamin Complex

    Not yet reported MDCPharma Produtos Farmaceuticos LTDA 74 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Lack of Appetite, Anorexia
    View official trial listing →
  • Status unknown NCT NCT01311336

    Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain

    Not yet reported University of Vermont 55 participants Est. completion 2013-06 7 sites
    Other conditions: Pegfilgrastim-induced Back and Leg Pain
    View official trial listing →
  • Status unknown NCT NCT01314989

    Cyproheptadine as an Appetite Stimulant

    Not yet reported St. Justine's Hospital 20 participants Est. completion 2012-01 1 site
    Other conditions: Failure to Thrive
    View official trial listing →
  • Completed NCT NCT01330017

    Effects of Phenylephrine on Nasal Congestion in Participants With Seasonal Allergic Rhinitis (P08156 AM2)(Completed)

    Not yet reported Bayer 539 participants Est. completion 2011-06
    Other conditions: Rhinitis, Seasonal Rhinitis
    View official trial listing →
  • Terminated NCT NCT01390441

    A Study of the Pharmacokinetics and Safety of MK-8808 (MK-8808-002)

    Not yet reported Merck Sharp & Dohme LLC 100 participants Est. completion 2014-04
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01413958

    Effects of Phenylephrine Extended-Release Tablets on Allergy-Related Nasal Congestion (P08498 AM1)

    Not yet reported Bayer 575 participants Est. completion 2011-10
    Other conditions: Seasonal Allergic Rhinitis
    View official trial listing →
  • Completed NCT NCT01451996

    The Efficacy of Claritin in Healthy Subjects

    Not yet reported University of Chicago 340 participants Est. completion 2012-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01469234

    A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712)

    Not yet reported Bayer 255 participants Est. completion 2011-11
    Other conditions: Rhinitis
    View official trial listing →
  • Completed NCT NCT01509885

    Cyproheptadine and Chlorpromazine Effects on Spasticity

    University of Alberta 20 participants Est. completion 2012-11 1 site
    Other conditions: Spinal Cord Injuries, Muscle Spasticity
    View official trial listing →
  • Completed NCT NCT01519856

    PIRLONG-PD Safety and Efficacy of Piribedil in Parkinson's Disease During Long Term Therapy

    Desitin Arzneimittel GmbH 908 participants Est. completion 2015-02 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01538693

    Molecular Markers of Neuroplasticity During Exercise in People With Incomplete Spinal Cord Injury

    Not yet reported T. George Hornby 30 participants Est. completion 2015-05 1 site
    Other conditions: Spinal Cord Injury
    View official trial listing →
  • Completed NCT NCT01673620

    A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484)

    Not yet reported Organon and Co 69 participants Est. completion 2012-10-10
    Other conditions: Allergic Rhinitis
    View official trial listing →
  • Terminated NCT NCT01675050

    A Placebo-controlled Crossover Trial Using Cyproheptadine To Treat Children With Functional Abdominal Pain

    Not yet reported University of Michigan 4 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Functional Abdominal Pain
    View official trial listing →
  • Completed NCT NCT01688570

    Mechanisms of Neuromuscular Fatigue Post Stroke

    Not yet reported Medical College of Wisconsin 27 participants Est. completion 2015-05 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01712009

    NOLAN: Naproxen or Loratadine and Neulasta

    Not yet reported Amgen 600 participants Est. completion 2015-03-18 83 sites
    Other conditions: Bone Pain in Stage I - III Breast Cancer
    View official trial listing →
  • Completed NCT NCT01940978

    A Study of Combination Therapy in Children With ADHD

    Not yet reported Douglas Sears 99 participants Est. completion 2015-03 1 site
    Other conditions: ADHD, Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder With Hyperactivity, Mental Disorders Diagnosed in Childhood, Attention Deficit and Disruptive Behavior Disorders
    View official trial listing →
  • Completed NCT NCT02007434

    Patient Experience Study of Deoxycholic Acid Injection

    Not yet reported Kythera Biopharmaceuticals 84 participants Est. completion 2014-06 1 site
    Other conditions: Moderate or Severe Submental Fullness
    View official trial listing →
  • Completed NCT NCT02305979

    Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies

    Wake Forest University Health Sciences 61 participants Est. completion 2017-09 1 site
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT02339714

    Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic Rhinitis

    Not yet reported Zhao Hong 98 participants Est. completion 2018-06 3 sites
    Other conditions: Rhinitis, Allergic, Perennial
    View official trial listing →
  • Terminated NCT NCT02392039

    Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma

    Not yet reported M.D. Anderson Cancer Center 1 participants Est. completion 2018-04-04 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT02418949

    Altering Activation Patterns Post-stroke

    Not yet reported Shirley Ryan AbilityLab 96 participants Est. completion 2022-03-23 1 site Stand-alone
    Cardiovascular disease Other conditions: Muscle Spasticity, Hemiparesis
    View official trial listing →
  • Completed NCT NCT02478398

    Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)

    Not yet reported Merck Sharp & Dohme LLC 1025 participants Est. completion 2018-11-19
    Other conditions: Rhinitis, Allergic, Seasonal
    View official trial listing →
  • Completed NCT NCT02495077

    Effects of Inhibiting Early Inflammation in Kidney Transplant Patients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 290 participants Est. completion 2021-07-23 15 sites
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT02513290

    Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine

    Not yet reported Universidade do Sul de Santa Catarina 73 participants Est. completion 2014-08
    Other conditions: Allergic Rhinitis
    View official trial listing →
  • Terminated NCT NCT02568007

    Effects of Cyproheptadine on Growth and Behavior in Pediatric Feeding Disorders

    Not yet reported Medical College of Wisconsin 4 participants Est. completion 2016-08 Stand-alone
    Other conditions: Feeding Behaviors
    View official trial listing →
  • Completed NCT NCT02576808

    Study of Efficacy and Safety of Ginger Extract Compared With Loratadine for Treatment of Allergic Rhinitis

    Not yet reported Thai Traditional Medical Knowledge Fund 80 participants Est. completion 2017-10 1 site
    Other conditions: Rhinitis,Allergic
    View official trial listing →
  • Completed NCT NCT02583594

    A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis

    Not yet reported Genzyme, a Sanofi Company 24 participants Est. completion 2021-03-01 1 site
    Other conditions: Progressive Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT02593747

    To Assess Bioequivalence of Loratadine Oral Solution/Syrup Versus Claritin Peach Syrup

    Not yet reported Bayer 54 participants Est. completion 2016-03 1 site
    Other conditions: Histamine H1 Antagonists, Non-Sedating
    View official trial listing →
  • Status unknown NCT NCT02653339

    Effectiveness of Qufeng Shengshi Fang on Treatment of Allergic Rhinitis.

    Not yet reported Peking Union Medical College Hospital 180 participants Est. completion 2018-08 1 site
    Other conditions: Rhinitis, Allergic, Perennial
    View official trial listing →
  • Completed NCT NCT02932774

    Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)

    Not yet reported Johnson & Johnson Consumer and Personal Products Worldwide 683 participants Est. completion 2001-07
    Other conditions: Allergic Rhinitis, Hay Fever, SAR, Rhinitis, Allergic, Seasonal
    View official trial listing →
  • Completed NCT NCT03004131

    MP-AzeFlu Allergen Chamber - Onset of Action Study

    Not yet reported MEDA Pharma GmbH & Co. KG 82 participants Est. completion 2017-03-29 1 site
    Other conditions: Seasonal Allergic Rhinitis
    View official trial listing →
  • Completed NCT NCT03151720

    A Study to Assess the Relative Bioavailability of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared to Clarityne Tablets

    Not yet reported Xian-Janssen Pharmaceutical Ltd. 28 participants Est. completion 2017-07-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03196531

    A Study to Assess the Bioequivalence of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared With Clarityne Tablets

    Not yet reported Xian-Janssen Pharmaceutical Ltd. 108 participants Est. completion 2018-03-31 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03372473

    Montelukast and Loratadine in Children With Asthma

    Not yet reported Innovacion y Desarrollo de Estrategias en Salud 80 participants Est. completion 2017-06-30
    Other conditions: Asthma in Children
    View official trial listing →
  • Completed NCT NCT03376594

    Benjakul Extract and Loratadine for Treatment Allergic Rhinitis Patients

    Not yet reported Thammasat University 60 participants Est. completion 2018-03-31 1 site
    Other conditions: Allergic Rhinitis
    View official trial listing →
  • Completed NCT NCT03443843

    A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure

    Not yet reported Bayer 82 participants Est. completion 2018-05-11 1 site
    Other conditions: Rhinitis, Allergic
    View official trial listing →
  • Completed NCT NCT03517930

    A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufacturers Under Fasted Conditions in Healthy Adult Subjects

    Not yet reported Bayer 52 participants Est. completion 2018-07-20 1 site
    Other conditions: Clinical Pharmacology
    View official trial listing →
  • Completed NCT NCT03517943

    A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufactuers Under Fed Conditions in Healthy Adult Subjects

    Not yet reported Bayer 29 participants Est. completion 2018-08-30 1 site
    Other conditions: Clinical Pharmacology
    View official trial listing →
  • Completed NCT NCT03593811

    Noninvasive Markers of Functional Nausea in Children

    Not yet reported Vanderbilt University Medical Center 42 participants Est. completion 2021-04-02 1 site
    Other conditions: Nausea
    View official trial listing →
  • Completed NCT NCT03640273

    Efficacy and Adverse Effects of Prapchompoothaweep Remedy and Loratadine for Treatment in AR Patients

    Not yet reported Thammasat University 72 participants Est. completion 2018-06-24 1 site
    Other conditions: Allergic Rhinitis, Adverse Drug Event, Quality of Life
    View official trial listing →
  • Completed NCT NCT03855228

    Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)

    Not yet reported Organon and Co 704 participants Est. completion 1995-08-07
    Other conditions: Rhinitis, Allergic
    View official trial listing →
  • Terminated NCT NCT03883386

    Loratadine for Improvement of Bone Pain in Patients With Chronic Granulocyte-Colony Stimulating Factor (G-CSF) Use

    Not yet reported University of Michigan 3 participants Est. completion 2019-10-18 1 site
    Other conditions: Bone Pain
    View official trial listing →
  • Completed NCT NCT04108104

    Clinical Outcome of a Patented Pharmaceutical Composition (KT-110) to Treat Alcohol Use Disorder While Avoiding Major Side Effects

    Not yet reported Kinnov Therapeutics 154 participants Est. completion 2022-01-31 35 sites Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT04162795

    A Study to Evaluate Cooling Sensation of an Allergy Product in Adults With a History of Allergies

    Not yet reported Bayer 468 participants Est. completion 2019-11-13 1 site
    Other conditions: Allergic Rhinitis
    View official trial listing →
  • Completed NCT NCT04179461

    Personalized Treatment Algorithms for Difficult-to-treat Asthma

    Not yet reported Children's Hospital Medical Center, Cincinnati 21 participants Est. completion 2019-10-03 1 site
    Other conditions: Asthma in Children
    View official trial listing →
  • Terminated NCT NCT04248712

    Antihistamines in Eosinophilic Esophagitis

    Not yet reported Mayo Clinic 1 participants Est. completion 2021-12-31 1 site
    Other conditions: Eosinophilic Esophagitis
    View official trial listing →
  • Active, not recruiting NCT NCT04488081

    I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

    Not yet reported QuantumLeap Healthcare Collaborative 1500 participants Est. completion 2030-07-31 36 sites Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT04820751

    Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial

    Not yet reported Ciusss de L'Est de l'Île de Montréal 200 participants Est. completion 2022-01-01 Stand-alone
    Other conditions: Viral Pneumonia, Serotonin Syndrome, Platelet Dysfunction
    View official trial listing →
  • Status unknown NCT NCT04876573

    Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19

    Not yet reported Ciusss de L'Est de l'Île de Montréal 60 participants Est. completion 2022-01-31 Stand-alone
    Other conditions: Viral Pneumonia, COVID-19 Pneumonia, Serotonin Syndrome, Platelet Dysfunction
    View official trial listing →
  • Status unknown NCT NCT04979221

    Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients With COVID-19

    Not yet reported Hospital de Clinicas de Porto Alegre 274 participants Est. completion 2022-02-28 1 site Stand-alone
    Other conditions: COVID-19 Pneumonia
    View official trial listing →
  • Completed NCT NCT05043350

    Combined Antihistaminics Therapy in COVID 19 Patients

    Not yet reported, Not yet reported Ain Shams University 214 participants Est. completion 2022-07-30 1 site
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT05087381

    Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in Community

    Not yet reported Chulalongkorn University 1200 participants Est. completion 2022-06-21 3 sites Stand-alone
    Other conditions: Treatment Efficacy
    View official trial listing →
  • Status unknown NCT NCT05190627

    Effect of Loratadine in Lymphangioleiomyomatosis

    Not yet reported Institut d'Investigació Biomèdica de Bellvitge 62 participants Est. completion 2023-12-30 6 sites
    Other conditions: Lymphangioleiomyomatosis
    View official trial listing →
  • Status unknown NCT NCT05243706

    Evaluation of The Effect of Loratadine Versus Diosmin/Hesperidin Combination on Vinca Alkaloids Induced Neuropathy

    Not yet reported Ain Shams University 90 participants Est. completion 2023-12-30
    Other conditions: Vinca Alkaloid Adverse Reaction
    View official trial listing →
  • Completed NCT NCT05265910

    A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis

    Not yet reported Andover Research Eye Institute 58 participants Est. completion 2022-04-23 1 site
    Other conditions: Allergic Conjunctivitis
    View official trial listing →
  • Completed NCT NCT05708274

    Pharmacological Agents for Chronic Spinal Cord Injury (SCI)

    Not yet reported Bronx VA Medical Center 25 participants Est. completion 2025-10-30 1 site Stand-alone
    Other conditions: Spinal Cord Injuries
    View official trial listing →
  • Completed NCT NCT05750875

    Gabapentin Versus Loratadine in Uremic Pruritus

    Not yet reported King Edward Medical University 64 participants Est. completion 2022-10-31 1 site
    Chronic kidney disease Other conditions: Pruritus, Uremia
    View official trial listing →
  • Terminated NCT NCT05753774

    Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders

    Not yet reported Biao Zou 47 participants Est. completion 2026-03-09 1 site
    Other conditions: Functional Gastrointestinal Disorders
    View official trial listing →
  • Completed NCT NCT06019728

    A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme

    Not yet reported Sanofi 8 participants Est. completion 2024-10-25 5 sites
    Other conditions: Fabry's Disease
    View official trial listing →
  • Completed NCT NCT06147622

    A Study to Assess the Pharmacokinetic Profile of Prazosin and Cyproheptadine

    Not yet reported Kinnov Therapeutics 12 participants Est. completion 2024-12-31 1 site Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT06175273

    Pediatric Oncology Nutrition Intervention Trial

    Not yet reported, Not yet reported Corey Hawes 20 participants Est. completion 2025-08-04 1 site Stand-alone
    Other conditions: Pediatric Cancer, Nutrition Related Cancer, Nutrition Aspect of Cancer, Muscle Loss, Malnutrition, Child
    View official trial listing →
  • Status unknown NCT NCT06217367

    Over-the-Counter Antihistamines & Heat Stress

    Not yet reported Lakehead University 16 participants Est. completion 2024-06 1 site
    Substance use disorder Other conditions: Heat Illness, Allergic Rhinitis, Heat Injury
    View official trial listing →
  • Status unknown NCT NCT06250400

    Efficacy and Safety of Histamine Human Immunoglobulin in the Treatment of Chronic Spontaneous Urticaria (CSU)

    Not yet reported Hangzhou Grand Biologic Pharmaceutical, Inc. 252 participants Est. completion 2025-12-31
    Other conditions: Chronic Spontaneous Urticaria
    View official trial listing →
  • Completed NCT NCT06265077

    Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients

    Not yet reported, Not yet reported Noha Mansour 58 participants Est. completion 2024-10-17 1 site
    Other conditions: Breast Cancer, Filgrastim Adverse Reaction
    View official trial listing →
  • Status unknown NCT NCT06396013

    A Multicentre Randomized Controlled Clinical Study on the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment Therapy for Psoriasis With Blood Stasis Syndrome.

    Not yet reported Beijing Hospital of Traditional Chinese Medicine 96 participants Est. completion 2026-07-31
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Status unknown NCT NCT06531707

    Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus Loratadine

    Not yet reported Laboratorios Silanes S.A. de C.V. 177 participants Est. completion 2025-02-20 1 site
    Other conditions: Common Cold
    View official trial listing →
  • Completed NCT NCT06751290

    The Use of Cyproheptadine in Pediatric Feeding Disorders

    Not yet reported University of Miami 18 participants Est. completion 2026-04-30 1 site Stand-alone
    Other conditions: Pediatric Feeding Disorder, Chronic, Avoidant Restrictive Food Intake Disorder
    View official trial listing →
  • Completed NCT NCT06955741

    A Study to Assess Drug Levels, Tolerability and Absolute Biological Availability of Single-dose of BMS-986446 in Healthy Participants

    Not yet reported Bristol-Myers Squibb 46 participants Est. completion 2025-09-11 2 sites
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT07006181

    Effectiveness of Cyproheptadine Hydrochloride Against Appetite to Improve Children's Nutritional Status

    Not yet reported Universitas Indonesia 44 participants Est. completion 2025-03-31 1 site Stand-alone
    Other conditions: Appetite Loss
    View official trial listing →
  • Completed NCT NCT07380178

    The Effect of Apple Fruit Extract (Malus Sylvestris Mill) as an Antioxidant and Anti-Inflammatory on Allergic Rhinitis

    Not yet reported Universitas Sebelas Maret 40 participants Est. completion 2025-07-05 1 site
    Other conditions: Rhinitis, Allergic, Perennial
    View official trial listing →
  • Not yet recruiting NCT NCT07532993

    Comparison of Antihistamine and Antileukotriene Add-On Therapy to Intranasal Corticosteroid in Allergic Rhinitis

    Not yet reported Liaquat National Hospital & Medical College 32 participants Est. completion 2027-05 1 site
    Other conditions: Allergic Rhinitis (AR)
    View official trial listing →
  • Completed NCT NCT07545382

    Rivastigmine as an Antidote for Clozapine-induced Central Nervous System Depression and Delirium

    Not yet reported Alexandria University 100 participants Est. completion 2026-04-15 1 site
    Other conditions: Anticholinergic Delirium, Clozapine Poisoning, Antipsychotic Toxicity, CNS Depression, Hypoactive Delirium, Tricyclic Antidepressant Poisoning, Procyclidine Induced Delirium
    View official trial listing →
  • Not yet recruiting NCT NCT07575464

    Efficacy of Auricular Acupressure Combined With Antihistamines in Patients With Wind-Heat Type Urticaria.

    Not yet reported University of Medicine and Pharmacy at Ho Chi Minh City 66 participants Est. completion 2026-07 1 site
    Other conditions: Auricular Acupressure, Wind-Heat Urticaria, Traditional Medicine
    View official trial listing →
  • Not yet recruiting NCT NCT07765914

    Zuberitamab in the First Episode of Paediatric Nephrotic Syndrome

    Not yet reported Children's Hospital of Fudan University 120 participants Est. completion 2028-12-31 9 sites Stand-alone
    Other conditions: Nephrotic Syndrome
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Cyproheptadine Hydrochloride, cyproheptadine hydrochloride solution, Cyproheptadine

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.